Julian N. Stern
Geen lopende functies
Oorsprong van het eerstegraads netwerk van Julian N. Stern
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Assertio Therapeutics, Inc.
Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL.
41
| Extinct | Pharmaceuticals: Major | 41 |
Public Company | Pharmaceuticals: Major | 38 | |
Pherin Pharmaceuticals, Inc.
Pherin Pharmaceuticals, Inc. BiotechnologyHealth Technology Pherin Pharmaceuticals, Inc. operates as a clinical stage company. It focuses on the development of its proprietary compounds pherines, for the acute treatment of neuropsychiatric and neuroendocrine conditions. The firm’s products include Aloradine, PH10, Salubrin-HF and PH15. The company was founded in 1991 and is headquartered in Los Altos, CA.
7
| Subsidiary | Biotechnology | 7 |
New York University
6
| College/University | Other Consumer Services | 6 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Julian N. Stern via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
Stanford University | College/University | Undergraduate Degree Corporate Officer/Principal Undergraduate Degree Undergraduate Degree Undergraduate Degree Graduate Degree Graduate Degree | |
ALZA CORPORATION | Pharmaceuticals: Major | Chairman Chief Administrative Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal Investor Relations Contact | |
The Trustees of Columbia University in The City of New York | College/University | Masters Business Admin Masters Business Admin Graduate Degree Graduate Degree Graduate Degree | |
PROTAGONIST THERAPEUTICS, INC. | Biotechnology | General Counsel Corporate Officer/Principal Chief Tech/Sci/R&D Officer Director/Board Member Director of Finance/CFO | |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree Masters Business Admin Doctorate Degree Corporate Officer/Principal Undergraduate Degree | |
University of California, Los Angeles | College/University | Doctorate Degree Doctorate Degree Graduate Degree Undergraduate Degree | |
PDL BIOPHARMA, INC. | Biotechnology | Chairman Director/Board Member Human Resources Officer Corporate Officer/Principal | |
The University of Chicago | College/University | Graduate Degree Masters Business Admin Graduate Degree Undergraduate Degree | |
University of California, Davis | College/University | Doctorate Degree Graduate Degree Undergraduate Degree Undergraduate Degree | |
Fibrogen Europe Oy
Fibrogen Europe Oy BiotechnologyHealth Technology Fibrogen Europe Oy develops and markets recombinant human collagens and gelatins for research purposes. It serves companies in the pharmaceutical, vaccine, medical device, diagnostic, industrial, food, cosmetic, and nutraceutical businesses. The company was founded on May 22, 1996 and is located at Helsinki, Finland. | Biotechnology | Director/Board Member Chairman Chief Executive Officer | |
University of California, Berkeley | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree | |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
AMGEN INC. | Pharmaceuticals: Major | General Counsel Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
San Francisco State University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
The University of Texas at Austin | College/University | Masters Business Admin Corporate Officer/Principal Doctorate Degree | |
University of Pennsylvania | College/University | Undergraduate Degree Graduate Degree Doctorate Degree | |
PERRIGO COMPANY PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Western Michigan University | College/University | Undergraduate Degree Graduate Degree | |
Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
FibroGen (China) Medical Technology Development Co. Ltd.
FibroGen (China) Medical Technology Development Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of FibroGen, Inc., FibroGen (China) Medical Technology Development Co., Ltd. is a biomedical technology company based in Beijing, China. FibroGen () is dedicated to developing new mechanisms of action or "best-in-class" innovative drugs and medical devices to meet the unmet clinical needs of Chinese patients. The Chinese company also provides a platform to report adverse events related to FibroGen roxadustat products. The company was founded in 2011. Christine Chung L. has been the CEO of the company since 2019. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
ALLERGAN, INC. | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal | |
Georgetown University | College/University | Doctorate Degree Doctorate Degree | |
The State Bar of California
The State Bar of California Miscellaneous Commercial ServicesCommercial Services The State Bar of California operates as an official attorney licensing agency. The non-profit company is based in San Francisco, CA. Elizabeth Rindskopf Parker has been the CEO of the company since 2015. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
University of Maryland | College/University | Undergraduate Degree Doctorate Degree | |
AUSPEX PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Harvard Medical School | College/University | Doctorate Degree Corporate Officer/Principal | |
Suomen Itsenäisyyden Juhlarahasto
Suomen Itsenäisyyden Juhlarahasto Investment ManagersFinance Suomen Itsenäisyyden Juhlarahasto is a Finnish innovation fund directly under the Finnish parliament. It primarily invests in foreign and national funds while making selected follow-up investments in Finnish start-ups and later-stage companies. It can consider investing in foreign companies if it is purposeful for the fund's goals. Its investment focus is in the well-being of the Finnish people, environment, and the economy. The size of its initial venture is up to EUR 2 million and its average investment period per company is from 4 to 10 years. | Investment Managers | President Director/Board Member | |
AFFYMAX, INC. | Biotechnology | Investor Relations Contact General Counsel | |
University of San Francisco | College/University | Masters Business Admin Undergraduate Degree | |
RELYPSA INC | Pharmaceuticals: Major | Investor Relations Contact General Counsel | |
Prometheus Laboratories, Inc.
Prometheus Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Prometheus Laboratories, Inc. develops and commercializes novel pharmaceutical and diagnostic products. Its enables physicians to provide individualized patient care. It applies the principles of personalized medicine to the diagnosis and treatment of gastrointestinal diseases and applies it to oncology. The firms markets and promotes pharmaceutical products and complementary proprietary diagnostic testing services. The company was founded by Jonathan Braun, Stephan R. Targan, Michael J. Walsh, and Scott L. Glenn in 1995 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | General Counsel Chief Executive Officer | |
Scios, Inc.
Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA. | Pharmaceuticals: Major | President Corporate Officer/Principal | |
JOHNSON & JOHNSON | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Human Resources Officer | |
TITAN PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer General Counsel | |
ADAMAS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | General Counsel Corporate Officer/Principal | |
Centocor, Inc.
Centocor, Inc. Medical SpecialtiesHealth Technology Centocor, Inc. manufactures healthcare products. Its products include avakine & reopro. The company was founded in 1979 by Hubert J. P. Schoemaker & Michael A. Wall and is headquartered in Horsham, PA. | Medical Specialties | Sales & Marketing Corporate Officer/Principal | |
Stanford Law School | College/University | Graduate Degree Graduate Degree |
Statistieken
Internationaal
Verenigde Staten | 46 |
Finland | 3 |
Verenigd Koninkrijk | 2 |
Ierland | 2 |
China | 2 |
Sectoraal
Health Technology | 30 |
Consumer Services | 18 |
Commercial Services | 4 |
Finance | 2 |
Operationeel
Director/Board Member | 244 |
Corporate Officer/Principal | 177 |
Undergraduate Degree | 72 |
Chairman | 70 |
Independent Dir/Board Member | 67 |
Sterkste connecties
Insiders | |
---|---|
G. Steven Burrill | 44 |
Rory Riggs | 32 |
Samuel Saks | 28 |
Kalevi Kurkijärvi | 21 |
Karen Dawes | 21 |
Russell Ellison | 20 |
Gerry Proehl | 19 |
Jeffrey Henderson | 18 |
David Goodman | 17 |
Gary Petersmeyer | 16 |
Vicente J. Anido | 16 |
Kin Hung Yu | 15 |
Roberto Pedro Rosenkranz | 15 |
Sylvia R. Wheeler | 14 |
Peter Staple | 13 |
- Beurs
- Insiders
- Julian N. Stern
- Bedrijfsconnecties